Acute myeloid leukemia (AML) encompasses multiple disease entities that differ with regard to marrow morphology, cytochemistry, immunophenotype, pretreatment clinical characteristics, and treatment outcome.
Krzysztof Mrózek, MD, PhD
Advertisement
Articles by Krzysztof Mrózek, MD, PhD
Advertisement
Latest Updated Articles
- Acute Myeloid Leukemia With Adverse Cytogenetic Risk
Published: August 3rd 2012 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
2
Porustobart/Tislelizumab Elicits Responses in MSS Metastatic Colorectal Cancer
3
Classifying High-Risk Patients With NDMM
4
Unraveling the Complexities of Proximal-Type Epithelioid Sarcoma of the Vulva
5
